1006 related articles for article (PubMed ID: 16873691)
1. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
2. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
3. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
[TBL] [Abstract][Full Text] [Related]
4. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats.
Kraegen EW; Saha AK; Preston E; Wilks D; Hoy AJ; Cooney GJ; Ruderman NB
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E471-9. PubMed ID: 16234268
[TBL] [Abstract][Full Text] [Related]
5. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.
Atkinson LL; Kozak R; Kelly SE; Onay Besikci A; Russell JC; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E923-30. PubMed ID: 12464581
[TBL] [Abstract][Full Text] [Related]
6. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
7. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
8. Decreased muscle acetyl-coenzyme A carboxylase 2 mRNA and insulin resistance in formerly obese subjects.
Rosa G; Manco M; Vega N; Greco AV; Castagneto M; Vidal H; Mingrone G
Obes Res; 2003 Nov; 11(11):1306-12. PubMed ID: 14627750
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
[TBL] [Abstract][Full Text] [Related]
10. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
11. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
[TBL] [Abstract][Full Text] [Related]
13. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
Beha A; Juretschke HP; Kuhlmann J; Neumann-Haefelin C; Belz U; Gerl M; Kramer W; Roden M; Herling AW
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389
[TBL] [Abstract][Full Text] [Related]
14. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
15. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle.
Lee WJ; Song KH; Koh EH; Won JC; Kim HS; Park HS; Kim MS; Kim SW; Lee KU; Park JY
Biochem Biophys Res Commun; 2005 Jul; 332(3):885-91. PubMed ID: 15913551
[TBL] [Abstract][Full Text] [Related]
16. Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle.
Lessard SJ; Chen ZP; Watt MJ; Hashem M; Reid JJ; Febbraio MA; Kemp BE; Hawley JA
Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E251-7. PubMed ID: 16118254
[TBL] [Abstract][Full Text] [Related]
17. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.
Steinberg GR; Rush JW; Dyck DJ
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E648-54. PubMed ID: 12441311
[TBL] [Abstract][Full Text] [Related]
18. Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin.
Palanivel R; Sweeney G
FEBS Lett; 2005 Sep; 579(22):5049-54. PubMed ID: 16137686
[TBL] [Abstract][Full Text] [Related]
19. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus.
Shafrir E; Ziv E; Saha AK; Ruderman NB
Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940
[TBL] [Abstract][Full Text] [Related]
20. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang Cc Cc; Itani SI; Lodish HF; Ruderman NB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16309-13. PubMed ID: 12456889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
